CUBT — Curative Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Curative Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	0	0.161	0.67
Net Total Accounts Receivable
Net Total Receivables	0	0.07	0.025
Prepaid Expenses
Total Current Assets	0	2.13	0.754
Accumulated Depreciation
Net Property, Plant And Equipment	0.003	0.002	0.007
Net Intangible Assets
Other Long Term Assets
Total Assets	0.04	2.27	2.41
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.125	0.665	0.73
Total Long Term Debt
Total Debt
Total Liabilities	0.125	0.665	0.73
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.085	1.61	1.68
Total Liabilities & Shareholders' Equity	0.04	2.27	2.41
Total Common Shares Outstanding
Total Preferred Shares Outstanding